Filed June 14, 2019
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`SAWAI USA, INC. AND SAWAI PHARMACEUTICAL CO., LTD.,
`Petitioners,
`v.
`BIOGEN MA INC.,
`Patent Owner.
`____________________________________________
`IPR2019-00789
`U.S. Patent No. 8,399,514
`____________________________________________
`
`
`
`
`
`BIOGEN EXHIBIT LIST
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`SAWAI USA, INC. AND SAWAI PHARMACEUTICAL CO., LTD.,
`Petitioners,
`v.
`BIOGEN MA INC.,
`Patent Owner.
`____________________________________________
`IPR2019-00789
`U.S. Patent No. 8,399,514
`____________________________________________
`
`
`
`
`
`BIOGEN EXHIBIT LIST
`
`
`
`Patent Owner’s Exhibit List
`
`Case No. IPR2019-00789
`
`Further to 37 CPR. § 42.63 (6), Patent Owner hereby submits a current listing
`
`of its exhibits. Exhibits 2006-2008, 2010-2012, 2014-2017 are being filed today.
`
`EXHIBIT
`
`DESCRIPTION
`
`Exhibit
`
`200 l
`
`Exhibit
`2002
`
`Exhibit
`2003
`
`Exhibit
`
`2004
`
`.
`.
`EXhlblt
`2005
`
`Press Release, Upsher-Smith’s Parent Company Forms Strategic
`Alliance with Sumitomo Corporation in US Generics Market (Nov.
`13, 2017) (available at https://www.upsher—
`smith.com/wpcontent/uploads/CO—PR—Sumitomo-Strategic-
`Alliance-USLFINAL. . (1
`
`Press Release, Sumitomo Corporation Participates in Generic
`Pharmaceutical Business in the US. (Nov- 13, 2017) (available at
`httpszl/WWW.sumitomocorp.com/en/jp/news/release/ZO1 7/group/20
`1 71 l l3_2)
`
`Summons in a Civil Action on Defendant Sawai USA Inc., Biogen
`Int’l GmbH & Biogen MA Inc. v. Sawai USA, Inc. & Sawai
`Pharmaceutical Co. Ltd., No. 1:17-cv-00875-LPS, Dkt. 5 (D. Del.
`July 5, 2017)
`
`Scheduling Order, Biogen Int ’1 GmbH & Biogen M4 Inc. v. Amneal
`Pharmaceuticals, et al., No. 1:17—00823-LPS, Dkt. 22 (D. Del.
`February 2, 2018)
`
`Transcript of May 14, 2019 teleconference with APJs Sheridan K.
`Snedden, Jennifer M. Chagnon, and Jacqueline T. Harlow, counsel
`for Patent Owner Biogen MA Inc. and counsel for Petitioner Sawai
`USA, Inc- and Sawai Pharmaceutical Co- Ltd.
`
`Exhibit
`2006
`
`Email from Andrew Kellogg, Supervisory Paralegal, Patent Trial
`and Appeal Board, USPTO (June 3, 2019)
`
`Egg)?“
`
`ANDA 210285 Tentative Approval Letter (available at
`https://www.accessdatafda.gov/drugsatfda_docs/appletter/2019/21
`
`02850ri115000TA ltr. D d
`
`Exhibit
`2008
`
`CenterWatch News Online, Sawai Pharmaceutical to acquire
`Upsher-Smith Laboratories U-S. generics business (Apr. 20, 2017)
`(available at https://www.centerwatch.com/news-
`online/20 l 7/04/20/sawai-pharmaceutical—acquire-upsher-smith—
`laboratories-u-s- ; enerics-business/
`
`
`
`
`
`
`
`Patent Owner’s Exhibit List
`
`Case No. IPR2019-00789
`
`EXHIBIT
`
`DESCRIPTION
`
`Exhibit
`
`2009
`
`Exhibit
`
`2010
`
`Exhibit
`
`201 1
`
`Exhibit
`
`20 1 2
`
`Exhibit
`
`201 3
`
`Exhibit
`
`20 14
`
`Exhibit
`
`2015
`
`Exhibit
`
`2016
`
`Exhibit
`
`201 7
`
`
`
`RESER VED
`
`Sawai Pharmaceutical Co., Ltd. Integrated Report 2018 (available
`at https://ssl4.eir—
`.arts.net/doc/4555/ir material for fiscal
`
`15/53096/00. d
`
`Sumitomo Corporation Integrated Report 2018 (available at
`https://www.sumitomocorp.com/—
`/media/Files/hq/ir/report/investors-guide/201 8/integrated-
`2018en. .df?la=en
`
`FY2018 Business Unit IR Meeting (May 28, 2018) (available at
`https://www.sumitomocorp.com/-
`/media/Files/hq/ir/explain/business/en/201 805281RQA_SHIGEN_
`ENG. D df?la=en
`
`RESER VED
`
`Press Release, Upsher-Smith’s Parent Company Completes Stake
`Transfer To Sumitomo Corporation In US Generics Market (Jan.
`5, 2018) (available at https://www.pmewswire.com/news-
`releases/upsher-smiths-parent-company—completes-stake-transfer-
`to-sumitomo-co u oration—in—us- enerics—market—300578294.html
`
`Sumitomo Corporation, Integrated Solution Provider for
`Pharmaceutical Industry “From upstream to downstream”
`(available at
`h D s://www.sumitomoco o .com/en/us/business/case/g ouo/236
`
`Complaint in a Civil Action, Biogen Int’l GmbH & Biogen 114A Inc.
`v. Sawai USA, Inc. & Sawai Pharmaceutical Co. Ltd, No. 1:17-cv-
`
`00875—LPS, Dkt. 1 D. Del. June 30, 2017
`
`Trial Transcript in a Civil Action, Procter & Gamble Pharm., Inc.
`et a]. v. Hoflmann-LaRoche, Inc. et al., No. 06-civ-34 (S.D.N.Y.
`Ma 25, 2006
`
`
`
`
`
`
`
`
`
`Dated: June 14, 2019
`
`
`
`
`
`
`
`Patent Owner’s Exhibit List
`Case No. IPR2019-00789
`
`
`
`
`
`Respectfully submitted,
`
`
`
`By: / Barbara C. McCurdy /
`Barbara C. McCurdy, Reg. No. 32,120
`Finnegan, Henderson, Farabow, Garrett
` & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4047
`Counsel for Patent Owner
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a copy of the foregoing Biogen Exhibit
`
`List and Exhibits 2006-2008, 2010-2012, 2014-2017 were served electronically via
`
`the PTAB electronic filing system and via email on June 14, 2019, in their entirety
`
`on the following:
`
`Brian Sodikoff
`Katten Muchin Rosenman LLP
`525 West Monroe Street
`Chicago, IL 60661-3693
`Telephone: (312) 902-5462
`E-mail: brian.sodikoff@kattenlaw.com
`
`Christopher B. Ferenc
`Katten Muchin Rosenman LLP
`2900 K Street NW
`North Tower - Suite 200
`Washington, DC 20007
`Telephone: (202) 625-3647
`E-mail: Christopher.ferenc@kattenlaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Petitioner has agreed to electronic service.
`
`Dated: June 14, 2019
`
`By: / Catherine A. Sadler /
`Catherine A. Sadler
`Case Manager
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
